Cargando…

Degarelix therapy for prostate cancer in a real-world setting: experience from the German IQUO (Association for Uro-Oncological Quality Assurance) Firmagon® registry

BACKGROUND: We investigated the use of the gonadotropin-releasing hormone (GnRH) antagonist degarelix in everyday clinical practice using registry data from uro-oncology practices in Germany. METHODS: Data were analysed retrospectively from the IQUO (Association for uro-oncological quality assurance...

Descripción completa

Detalles Bibliográficos
Autores principales:	Geiges, Götz, Harms, Thomas, Rodemer, Gerald, Eckert, Ralf, König, Frank, Eichenauer, Rolf, Schroder, Jörg
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2015
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4681133/ https://www.ncbi.nlm.nih.gov/pubmed/26674089 http://dx.doi.org/10.1186/s12894-015-0116-4

Ejemplares similares

Robotics in uro-oncologic surgery
por: De Lorenzis, Elisa, et al.
Publicado: (2013)

Positron emission tomography in uro-oncology
por: Hain, S F
Publicado: (2005)

Evaluation of degarelix in the management of prostate cancer
por: Van Poppel, Hendrik
Publicado: (2010)

Telehealth in Uro-oncology Beyond the Pandemic: Toll or Lifesaver?
por: Rodler, Severin, et al.
Publicado: (2020)

Immune Checkpoint Inhibitors in Uro-Oncology: Urgent Call for Biomarkers
por: Pichler, Renate
Publicado: (2020)

COVID-19 research: promising tracks leading to uro-oncology
por: Tamás, Fazekas, et al.
Publicado: (2020)

Value of multiphoton microscopy in uro-oncology: a narrative review
por: Treacy, Patrick-Julien, et al.
Publicado: (2023)

External Validation of the ASSURE Model for Predicting Oncological Outcomes After Resection of High-risk Renal Cell Carcinoma (RESCUE Study: UroCCR 88)
por: Khene, Zine-Eddine, et al.
Publicado: (2021)

Degarelix and its therapeutic potential in the treatment of prostate cancer
por: Doehn, Christian, et al.
Publicado: (2009)

Real-World Evidence Prediction of a Phase IV Oncology Trial: Comparative Degarelix vs Leuprolide Safety
por: Merola, David, et al.
Publicado: (2022)

Nefro-Uro /
Publicado: (2018)

Correction to: COVID-19 research: promising tracks leading to uro-oncology
por: Fazekas, Tamás, et al.
Publicado: (2020)

Application of Mass Spectrometry Imaging in Uro-Oncology: Discovering Potential Biomarkers
por: Czétány, Péter, et al.
Publicado: (2022)

Concerns in Redirecting Uro-oncologic Patients During COVID-19 Pandemic
por: Campodonico, Fabio, et al.
Publicado: (2020)

The Uro-oncology Patient and Vaccination Against SARS-CoV-2
por: Rodriguez Socarrás, Moises, et al.
Publicado: (2021)

Editorial: Technology advancements, social media and innovations in uro-oncology and endourology
por: Hameed, B M Zeeshan, et al.
Publicado: (2022)

Item analysis of G8 screening in uro-oncologic geriatric patients
por: Bouzan, J., et al.
Publicado: (2023)

Investigation of the GnRH antagonist degarelix isomerization in biological matrices
por: Ferrazzano, Lucia, et al.
Publicado: (2023)

The Shift Towards Digital Appointments: the Response to COVID-19 Affecting Uro-Oncology
por: Scott, E., et al.
Publicado: (2021)

Impact of COVID-19 on Uro-Oncological Patients: A Comprehensive Review of the Literature
por: Gavi, Filippo, et al.
Publicado: (2023)

Essentials of Uro-Radiology
por: Kabala, J. E.
Publicado: (1991)

Haema-Uro-Chrome
Publicado: (1914)

Uro-oncologic patient management during the COVID-19 pandemic: survey findings from an Italian oncologic hub
por: Luzzago, Stefano, et al.
Publicado: (2021)

An update on the use of degarelix in the treatment of advanced hormone-dependent prostate cancer
por: Rick, Ferenc G, et al.
Publicado: (2013)

Degarelix treatment is compatible with diabetes and antithrombotic therapy in patients with prostate cancer
por: Tokiwa, Suguru, et al.
Publicado: (2017)

Efficacy of Degarelix in the Neoadjuvant Setting in Managing Locally Advanced Prostate Cancer
por: Sankaran, Sindhu, et al.
Publicado: (2023)

The Experiences of Specialist Nurses Working Within the Uro-oncology Multidisciplinary Team in the United Kingdom
por: Punshon, Geoffrey, et al.
Publicado: (2017)

High-Risk Prostate Cancer: A Very Challenging Disease in the Field of Uro-Oncology
por: Napodano, Giorgio, et al.
Publicado: (2021)

Strategies to successfully prevent COVID-19 outbreak in vulnerable uro-oncology patient population
por: Tamalunas, Alexander, et al.
Publicado: (2022)

Impact of COVID-19 pandemic on prostate cancer outcomes at an uro-oncology referral center
por: Andrade, Guilherme Miranda, et al.
Publicado: (2023)

Impact of COVID-19 crisis on medical care of patients with metastasized uro-oncologic disease under systemic cancer therapy: a multicenter study in German university hospitals
por: Struck, Julian P., et al.
Publicado: (2021)

Hospital rating websites play a minor role for uro-oncologic patients when choosing a hospital for major surgery: results of the German multicenter NAVIGATOR-study
por: Groeben, Christer, et al.
Publicado: (2023)

COVID-19 pandemic impact on uro-oncological disease outcomes at an Italian tertiary referral center
por: Oderda, Marco, et al.
Publicado: (2021)

Evaluation of comorbidity indices in determining the most suitable candidates for uro-oncological surgeries in elderly men
por: Selvi, Ismail, et al.
Publicado: (2021)

Response to Degarelix After Resistance to Leuprolide in a Patient With Metastatic Prostate Cancer
por: Lazenby, Mark
Publicado: (2012)

Prostate Cancer-Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix
por: Ong, Shawn Y., et al.
Publicado: (2015)

Mistaken administration of a repeat loading dose of Degarelix leading to acute psychosis
por: Hamdoon, Musaab, et al.
Publicado: (2021)

Impact of Previous Nephrectomy on Clinical Outcome of Metastatic Renal Carcinoma Treated With Immune-Oncology: A Real-World Study on Behalf of Meet-URO Group (MeetUro-7b)
por: Stellato, Marco, et al.
Publicado: (2021)

Local and systemic morbidities of de novo metastatic prostate cancer in Singapore: insight from 685 consecutive patients from a large prospective Uro-oncology registry
por: Tan, Yu Guang, et al.
Publicado: (2020)

A Guide for Oncologic Patient Management during Covid-19 Pandemic: The Initial Experience of an Italian Oncologic Hub with Exemplificative Focus on Uro-Oncologic Patients
por: Mistretta, Francesco A., et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_ms6j3301qk1gtb9io9pobm8vht